Candesartan cilexetil
- Level
- Commodity
- Parent
- 51431900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51431904This classification denotes an angiotensin ii receptor antagonist with the molecular formula C33H34N6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R85M2X0D68, chemically known as 1h-benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2-(1h-tetrazol-5-yl)(1,1-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)- but more generally known as candesartan cilexetil, which bears US NIH Compound Identifier 2540. European Medicines Agency schedules Candesartan cilexetil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13222MIG. Most nations, for tariff and trade purposes, schedule candesartan cilexetil under HS 29339990 and SITC 51577. As of Q4 2014, CANDESARTAN CILEXETIL remains US FDA's Preferred Term for this commodity. Candesartan cilexetil bears US NLM identifiers UMLS ID C0527379 and NCI Concept Code C28903. SMILES: CCOC1NC2CCCC(C2N1CC3CCC(CC3)C4CCCCC4C5[NH]NNN5)C(=O)OC(C)OC(=O)OC6CCCCC6.
Same parent
Under 51431900 · 6Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.